Literature DB >> 11204949

Quinazoline derivatives with antitubercular activity.

J Kunes1, J Bazant, M Pour, K Waisser, M Slosárek, J Janota.   

Abstract

4-Quinazolinol was prepared by the reaction of anthranilic acid and formamide. The hydroxy group was converted into the thiol function by treatment with phosphorus(V)sulfide, and the subsequent alkylation of the thiol group was carried out with alkylhalides under the conditions of phase-transfer catalysis. The structure of the substances was confirmed by 1H, 13C NMR, IR, and MS. Most of the synthesized compounds exhibited antimycobacterial activity against the strains of Mycobacterium tuberculosis, Mycobacerium avium, Mycobacterium fortuitum, Mycobacterium kansasii and Mycobacterium intracellulare. 4-(S-Butylthio)quinazoline (3c) was even more active than isoniazide against atypical strains of mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204949     DOI: 10.1016/s0014-827x(00)00100-2

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  14 in total

1.  Possible inhibition of hydroxy methyl glutaryl CoA reductase activity by nicotinic acid and ergosterol: as targeting for hypocholesterolemic action.

Authors:  Said S Moselhy; I H Kamal; Taha A Kumosani; E A Huwait
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

2.  Synthesis and biological evaluation of cationic fullerene quinazolinone conjugates and their binding mode with modeled Mycobacterium tuberculosis hypoxanthine-guanine phosphoribosyltransferase enzyme.

Authors:  Manishkumar B Patel; Sivakumar Prasanth Kumar; Nikunj N Valand; Yogesh T Jasrai; Shobhana K Menon
Journal:  J Mol Model       Date:  2013-04-30       Impact factor: 1.810

3.  Synthesis and Antimicrobial Screening of Pyrazolo-3-Aryl Quinazolin-4(3H)ones.

Authors:  M B Deshmukh; S Patil; S S Patil; S D Jadhav
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

4.  The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats.

Authors:  Fawzia M Refaie; Amr Y Esmat; Soad M Abdel Gawad; Aida M Ibrahim; Mona A Mohamed
Journal:  Lipids Health Dis       Date:  2005-10-04       Impact factor: 3.876

Review 5.  Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives.

Authors:  Mohammad Asif
Journal:  Int J Med Chem       Date:  2014-11-12

6.  2-(4-Chloro-phen-yl)-4-phenyl-1,2-di-hydro-quinazoline.

Authors:  Chamseddine Derabli; Raouf Boulcina; Sofiane Bouacida; Hocine Merazig; Abdelmadjid Debache
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-19

7.  Molecular docking and biological evaluation of some thioxoquinazolin-4(3H)-one derivatives as anticancer, antioxidant and anticonvulsant agents.

Authors:  Danah S Al-Shamary; Monirah A Al-Alshaikh; Nabila Abdelshafy Kheder; Yahia Nasser Mabkhot; Syed Lal Badshah
Journal:  Chem Cent J       Date:  2017-05-31       Impact factor: 4.215

8.  A new synthetic route to original sulfonamide derivatives in 2-trichloromethylquinazoline series: a structure-activity relationship study of antiplasmodial activity.

Authors:  Nicolas Primas; Pierre Verhaeghe; Anita Cohen; Charline Kieffer; Aurélien Dumètre; Sébastien Hutter; Sylvain Rault; Pascal Rathelot; Nadine Azas; Patrice Vanelle
Journal:  Molecules       Date:  2012-07-05       Impact factor: 4.411

9.  Isoxazolidine Conjugates of N3-Substituted 6-Bromoquinazolinones-Synthesis, Anti-Varizella-Zoster Virus, and Anti-Cytomegalovirus Activity.

Authors:  Magdalena Grabkowska-Drużyc; Graciela Andrei; Dominique Schols; Robert Snoeck; Dorota G Piotrowska
Journal:  Molecules       Date:  2018-07-28       Impact factor: 4.411

10.  Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.

Authors:  K Waisser; K Drazková; J Cizmárik; J Kaustová
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.